EGRP News Flash - April 11, 2012
NCI Issues Omnibus R03 and R21 Funding Opportunity Announcements
The National Cancer Institute (NCI) recently announced the issuance of Funding Opportunity Announcements (FOA) for the Small Grants Program for Cancer Research (R03) and the Exploratory/Developmental Research Grant Program (R21).
NCI Omnibus R03 FOA - This FOA supports discrete, well-defined projects in any area of cancer research using the NIH R03 Small Research Grant mechanism. Examples of appropriate projects include, but are not limited to, the following:
- Pilot or feasibility studies,
- Secondary analysis of existing data,
- Small, self-contained research projects,
- Development of research methodology, and
- Development of new research technology.
A project period of up to two years may be requested with a budget for direct costs of up to $50,000 per year.
NCI Omnibus R21 FOA - This FOA is to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research in all areas relevant to the mission of NCI. These studies may involve considerable risk but may lead to a breakthrough in a particular area, and/or to development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical). Applications submitted under this mechanism should have a clear potential to break new ground and/or extend previous discoveries toward new directions or applications.
Applications for R21 awards should describe projects distinct from those supported through the traditional Research Project Grant (R01) mechanism. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. Conversely, long-term projects, or projects designed to increase knowledge in a well-established area, will not be considered for R21 awards. Projects of limited cost or scope that use widely accepted approaches and methods within well-established fields are better suited for the R03 mechanism.
The maximum project period is two years, and the combined budget for direct costs for the 2-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
For both FOAs, the earliest submission date is May 16, 2012, and they expire September 8, 2015. Standard due dates apply.
Investigators are encouraged to contact their assigned EGRP Program Director (PD) for grants-related questions and advice. Investigators who do not have an assigned PD are encouraged to view the EGRP staff list and contact the appropriate person with scientific interests related to their area of research.
Access the NIH Guide for Grants and Contracts for details: